Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer
Genes · 2025
DOI: 10.3390/genes16050527 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Wenkang Niu und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Science, Shihezi University, Shihezi 832000, China. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Prostatic Neoplasms, Gene Regulatory Networks. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Prostate cancer (PCa) is the most frequently diagnosed malignancy in the male genitourinary tract. However, the regulatory mechanism of competitive endogenous RNAs (ceRNAs) in PCa remains unclear. In this study, we first performed immune scores of mRNA data from 481 PCa samples using single-sample Gene Set Enrichment Analysis (ssGSEA). Based on the immune scores, we then evaluated the tumor immune microenvironment and analyzed 28 types of immune cells in PCa, we constructed a comprehensive network with four lncRNAs (MEG3, PCAT1, SNHG19, TRG-AS1), three miRNAs (hsa-miR-488-3p, hsa-miR-210-5p, hsa-miR-137), and twenty-seven mRNAs (including H2AFJ, THBS1, HPGD). Among the 28 immune cell types, seven immune cell types were found to be significantly associated with clinical characteristics. These network nodes have prognostic significance in multiple cancers and play critical roles in malignancy development, indicating the network’s predictive capability. We also observed a strong correlation (r = 0.6) between T-helper type 1 (Th1) cells and lncRNA network modules. The network connectivity highlights the association between immune therapy biomarkers for PCa, particularly those related to H2AFJ, THBS1, and HPGD. These findings provide valuable insights into the ceRNA regulatory network and its implications for immune-based therapies in PCa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Science, Shihezi University, Shihezi 832000, China.
- Key Laboratory of Oasis Town and Mountain-Basin System Ecology of Bingtuan, Shihezi University, Shihezi 832000, China.
ORCID-Profile: Wenkang Niu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Niu, W., Zhang, T., & Ma, L. (2025). Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer. Genes. https://doi.org/10.3390/genes16050527
Vancouver
Niu W, Zhang T, Ma L. Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer. Genes. 2025. doi:10.3390/genes16050527
BibTeX
@article{Niu2025,
author = {Niu, Wenkang and Zhang, Tingting and Ma, Lei},
title = {Competitive Endogenous RNA Network Involving Immune Subgroups, Infiltration, and lncRNAs in Prostate Cancer},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16050527}
}
EUVIMED